|
 |
|
|||||||
|
|||||||||
Copyright ©ERS Journals Ltd 2004
The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation
Depts of 1 Pathology, and 2 Pulmonology, University Hospital Groningen
CORRESPONDENCE: B.W.M. Willemse, Dept of Pathology, University Hospital Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands. Fax: 31 503632510. E-mail: b.w.m.willemse@path.azg.nl
Keywords: chronic obstructive pulmonary disease, inflammation, review, smoking cessation
Received: February 5, 2003
Accepted October 29, 2003
Abstract
Smoking is the main risk factor in the development of chronic obstructive pulmonary disease (COPD), and smoking cessation is the only effective treatment for avoiding or reducing the progression of this disease.
Despite the fact that smoking cessation is a very important health issue, information about the underlying mechanisms of the effects of smoking cessation on the lungs is surprisingly scarce. It is likely that the reversibility of smoke-induced changes differs between smokers without chronic symptoms, smokers with nonobstructive chronic bronchitis and smokers with COPD. This review describes how these three groups differ regarding the effects of smoking cessation on respiratory symptoms, lung function (forced expiratory volume in one second), airway hyperresponsiveness, and pathological and inflammatory changes in the lung.
Smoking cessation clearly improves respiratory symptoms and bronchial hyperresponsiveness, and prevents excessive decline in lung function in all three groups.
Data from well-designed studies are lacking regarding the effects on inflammation and remodelling, and the few available studies show contradictory results. In chronic obstructive pulmonary disease, a few histopathological studies suggest that airway inflammation persists in exsmokers. Nevertheless, many studies have shown that smoking cessation improves the accelerated decline in forced expiratory volume in one second, which strongly indicates that important inflammatory and/or remodelling processes are positively affected.
This article has been cited by other articles:
|
|
 |
|
  K. Barraclough Chronic cough in adults BMJ, April 24, 2009; 338(apr24_1): b1218 - b1218. [Full Text]
|
|
|
|
 |
|
 M. Quaak, C. P. van Schayck, A. M. Knaapen, and F. J. van Schooten Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases? Eur. Respir. J., March 1, 2009; 33(3): 468 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Luppi, F. Franco, B. Beghe, and L. M. Fabbri Treatment of Chronic Obstructive Pulmonary Disease and Its Comorbidities Proceedings of the ATS, December 1, 2008; 5(8): 848 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. S. Godtfredsen, T. H. Lam, T. T. Hansel, M. E. Leon, N. Gray, C. Dresler, D. M. Burns, E. Prescott, and J. Vestbo COPD-related morbidity and mortality after smoking cessation: status of the evidence Eur. Respir. J., October 1, 2008; 32(4): 844 - 853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers Eur. Respir. J., February 1, 2008; 31(2): 416 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. H. Walters, D. W. Reid, D. P. Johns, and C. Ward Nonpharmacological and pharmacological interventions to prevent or reduce airway remodelling Eur. Respir. J., September 1, 2007; 30(3): 574 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Tonnesen, L. Carrozzi, K. O. Fagerstrom, C. Gratziou, C. Jimenez-Ruiz, S. Nardini, G. Viegi, C. Lazzaro, I. A. Campell, E. Dagli, et al. Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy Eur. Respir. J., February 1, 2007; 29(2): 390 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Baser, V. R. Shannon, G. A. Eapen, C. A. Jimenez, A. Onn, E Lin, and R. C. Morice Smoking Cessation After Diagnosis of Lung Cancer Is Associated With a Beneficial Effect on Performance Status Chest, December 1, 2006; 130(6): 1784 - 1790. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D M Mannino Underdiagnosed chronic obstructive pulmonary disease in England: new country, same story. Thorax, December 1, 2006; 61(12): 1032 - 1034. [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Gerbase, C. Schindler, J.-P. Zellweger, N. Kunzli, S. H. Downs, O. Brandli, J. Schwartz, M. Frey, L. Burdet, T. Rochat, et al. Respiratory Effects of Environmental Tobacco Exposure Are Enhanced by Bronchial Hyperreactivity Am. J. Respir. Crit. Care Med., November 15, 2006; 174(10): 1125 - 1131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Verbanck, D. Schuermans, M. Paiva, M. Meysman, and W. Vincken Small Airway Function Improvement after Smoking Cessation in Smokers without Airway Obstruction Am. J. Respir. Crit. Care Med., October 15, 2006; 174(8): 853 - 857. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Menzies, A. Nair, P. A. Williamson, S. Schembri, M. Z. H. Al-Khairalla, M. Barnes, T. C. Fardon, L. McFarlane, G. J. Magee, and B. J. Lipworth Respiratory symptoms, pulmonary function, and markers of inflammation among bar workers before and after a legislative ban on smoking in public places. JAMA, October 11, 2006; 296(14): 1742 - 1748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Hedlund, B. Jarvholm, and B. Lundback Persistence of respiratory symptoms in ex-underground iron ore miners Occup. Med., September 1, 2006; 56(6): 380 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Hedlund, K. Eriksson, and E. Ronmark Socio-economic status is related to incidence of asthma and respiratory symptoms in adults Eur. Respir. J., August 1, 2006; 28(2): 303 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Chaudhuri, E. Livingston, A. D. McMahon, J. Lafferty, I. Fraser, M. Spears, C. P. McSharry, and N. C. Thomson Effects of Smoking Cessation on Lung Function and Airway Inflammation in Smokers with Asthma Am. J. Respir. Crit. Care Med., July 15, 2006; 174(2): 127 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Barnes, B. Chowdhury, S. A. Kharitonov, H. Magnussen, C. P. Page, D. Postma, and M. Saetta Pulmonary Biomarkers in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 1, 2006; 174(1): 6 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe Update in chronic obstructive pulmonary disease 2005. Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1056 - 1065. [Full Text] [PDF]
|
|
|
|
|
|
S. Chinn, D. Jarvis, C. Svanes, and P. Burney Sources of variation in forced expiratory volume in one second and forced vital capacity. Eur. Respir. J., April 1, 2006; 27(4): 767 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T S Lapperre, D S Postma, M M E Gosman, J B Snoeck-Stroband, N H T ten Hacken, P S Hiemstra, W Timens, P J Sterk, T Mauad, and on behalf of the GLUCOLD Study Group Relation between duration of smoking cessation and bronchial inflammation in COPD Thorax, February 1, 2006; 61(2): 115 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W. Ind COPD disease progression and airway inflammation: uncoupled by smoking cessation Eur. Respir. J., November 1, 2005; 26(5): 764 - 766. [Full Text] [PDF]
|
|
|
|
|
|
B. W. M. Willemse, N. H. T. ten Hacken, B. Rutgers, I. G. A. T. Lesman-Leegte, D. S. Postma, and W. Timens Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers Eur. Respir. J., November 1, 2005; 26(5): 835 - 845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Belmonte Cholinergic Pathways in the Lungs and Anticholinergic Therapy for Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2005; 2(4): 297 - 304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chinn, D. Jarvis, C. M. Luczynska, U. Ackermann-Liebrich, J. M. Anto, I. Cerveri, R. de Marco, T. Gislason, J. Heinrich, C. Janson, et al. An Increase in Bronchial Responsiveness Is Associated with Continuing or Restarting Smoking Am. J. Respir. Crit. Care Med., October 15, 2005; 172(8): 956 - 961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bohadana, F. Nilsson, and Y. Martinet Detecting Airflow Obstruction in Smoking Cessation Trials: A Rationale for Routine Spirometry Chest, September 1, 2005; 128(3): 1252 - 1257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-A. Lin, C.-C. Yeh, M.-S. Lee, C.-T. Wu, S.-L. Lin, and C.-S. Wong Prolonged Injection Time and Light Smoking Decrease the Incidence of Fentanyl-Induced Cough Anesth. Analg., September 1, 2005; 101(3): 670 - 674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Shaker, N. Maltbaek, P. Brand, S. Haeussermann, and A. Dirksen Quantitative computed tomography and aerosol morphometry in COPD and {alpha}1-antitrypsin deficiency Eur. Respir. J., January 1, 2005; 25(1): 23 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N.C. Thomson, R. Chaudhuri, and E. Livingston Asthma and cigarette smoking Eur. Respir. J., November 1, 2004; 24(5): 822 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. F. Chung, G. Caramori, D. A. Groneberg, J. Lamela, F. Vega, J. Blanco, J. C. Hogg, and P. J. Barnes Airway Obstruction in Chronic Obstructive Pulmonary Disease N. Engl. J. Med., September 30, 2004; 351(14): 1459 - 1461. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |